Cargando…
Dysfunctional Coagulation in COVID-19: From Cell to Bedside
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19), which can induce multisystem disease. Human angiotensin-converting enzyme 2 (ACE2) widely expressing in arterial and venous endothelial cells and arterial smooth muscle cells has been identified...
Autores principales: | Wang, Jie, Saguner, Ardan M., An, Jiaqi, Ning, Yuye, Yan, Yang, Li, Guoliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7274265/ https://www.ncbi.nlm.nih.gov/pubmed/32504450 http://dx.doi.org/10.1007/s12325-020-01399-7 |
Ejemplares similares
-
Atrial cardiomyopathy: from cell to bedside
por: Li, Mengmeng, et al.
Publicado: (2022) -
Coagulation cascade in sepsis: getting from bench to bedside?
por: Brown, Glen
Publicado: (2003) -
From bench to bedside
por: Verdant, Colin L
Publicado: (2012) -
Back to the bedside: the role of bedside teaching in the modern era
por: Qureshi, Zeshan
Publicado: (2014) -
Does Post-COVID-19 Erectile Dysfunction Improve over Time?
por: Gök, Alper, et al.
Publicado: (2023)